Diagnostic strategy for oncology patients with acute respiratory failure

Minerva Anestesiologica

Volumn 78, Issue 12, 2012, Pages 1404-1414

  Blot, F ^a   Chalumeau Lemoine, L ^a   Marty, A ^a   Chtara, K ^a   Bouzidi, H ^a   Stoclin, A ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Bronchoalveolar lavage; Hematological neoplasms; Intensive care units; Neoplasms; Respiratory insufficiency

Indexed keywords

BEVACIZUMAB; BIOLOGICAL MARKER; BORTEZOMIB; DOCETAXEL; FLUDARABINE; GEFITINIB; GEMCITABINE; IMATINIB; IRINOTECAN; OXALIPLATIN; PACLITAXEL; RITUXIMAB; SEDATIVE AGENT; SUNITINIB; THALIDOMIDE; TOPOTECAN; TRASTUZUMAB;

ACUTE RESPIRATORY FAILURE; ALLERGIC PNEUMONITIS; BIOARTIFICIAL LIVER; BLOOD ANALYSIS; BRONCHIOLITIS OBLITERANS; CANCER PATIENT; CARDIOTOXICITY; COMPUTER ASSISTED TOMOGRAPHY; ECHOCARDIOGRAPHY; FIBEROPTIC BRONCHOSCOPY; FIBROSING ALVEOLITIS; HEMOPTYSIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOFLUORESCENCE TEST; INTERSTITIAL PNEUMONIA; LUNG HEMORRHAGE; LUNG LAVAGE; NEOPLASM; NEUTROPENIA; NON INVASIVE PROCEDURE; PLEURA EFFUSION; PNEUMONIA; POLYMERASE CHAIN REACTION; RADIODENSITOMETRY; RESPIRATORY TRACT DISEASE; REVIEW; SOLID TUMOR; SPUTUM ANALYSIS; STEM CELL TRANSPLANTATION; THROMBOEMBOLISM; URINALYSIS;

HUMANS; INDIVIDUALIZED MEDICINE; NEOPLASMS; NEUTROPENIA; RESPIRATORY INSUFFICIENCY; RISK ASSESSMENT; STEM CELL TRANSPLANTATION;

EID: 84871520657     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Mokart D, Etienne A, Esterni B, Brun JP, Chow-Chine L, Sannini A et al. Critically ill cancer patients in the intensive care unit: short-term outcome and 1-year mortality. Acta Anesthesiol Scand 2012;56:178-89.
2. Lecuyer L, Chevret S, Thiery G, Darmon M, Schlemmer B, Azoulay E. The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 2007;35:808-14.
3. Blot F, Guiguet M, Nitenberg G, Leclercq B, Gachot B, Escudier B. Prognostic factors for neutropenic patients in an intensive care unit. Respective roles of underlying malignancies and acute organ failures. Eur J Cancer 1997;33:1031-7.
4. Mayaud C, Cadranel J. A persistent challenge: the diagnosis of respiratory disease in the non-AIDS immunocompromised host. Thorax 2000;55:511-7.
5. Azoulay E, Mokart D, Lambert J, Lemiale V, Rabbat A, Kouatchet A et al. Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 2010;182:1038-46.
6. Azoulay E, Mokart D, Rabbat A, Schlemmer B. Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data. Crit Care Med 2008;36:100-7.
7. Azoulay E, Schlemmer B. Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med. 2006;32:808-22.
8. Shannon VR, Andersson BS, Lei X, Champlin RE, Kontoyiannis DP. Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation. Bone Marrow Transplant 2010;45:647-55.
9. Hilbert G, Gruson D, Vargas F, Valentino R, Gbikpi-Benissan G, Dupon M et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001;344:481-7.
10. Cuttner J, Conjalka MS, Reilly M, Goldberg J, Reisman A, Meyer RJ et al: Association of monocytic leukemia in patients with extreme leukocytosis. Am J Med 1980;69:555-8.
11. Myers TJ, Cole SR, Klatsky AU, Hild DH. Respiratory failure due to pulmonary leukostasis following chemotherapy of acute nonlymphocytic leukemia. Cancer. 1983;51:1808-13.
12. Azoulay E, Canet E, Raffoux E, Lengliné E, Lemiale V, Vincent F et al. Dexamethasone in Patients with Acute Lung Injury from Acute Monocytic Leukemia. Eur Respir J 2011 Aug 4
13. Massard C, Plantade A, Gross-Goupil M, Loriot Y, Besse B, Raynard B et al. Poor prognosis nonseminomatous germcell tumours (NSGCTs): should chemotherapy doses be reduced at first cycle to prevent acute respiratory distress syndrome in patients with multiple lung metastases? Ann Oncol 2010;21:1585-8.
14. Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 2003;97:2869-79.
15. White DA, Rankin JA, Stover DE, Gellene RA, Gupta S. Methotrexate pneumonitis. Bronchoalveolar lavage findings suggest an immunologic disorder. Am Rev Respir Dis 1989;139:18-21.
16. Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009;15:1143-238
17. Soubani AO, Miller KB, Hassoun PM. Pulmonary complications of bone marrow transplantation. Chest 1996;109:1066-77.
18. Greene RE, Schlamm HT, Oestmann JW, Stark P, Durand C, Lortholary O et al. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis 2007;44:373-9.
19. Dimopoulou I, Bamias A, Lyberopoulos P, Dimopoulos MA. Pulmonary toxicity from novel antineoplastic agents. Ann Oncol 2006 March;17:372-9.
20. Chu TF, Rupnick MA, Kerkela R, Dallabrida SM, Zurakowski D, Nguyen L et al. Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib. Lancet 2007;370:2011-9.
21. Telli ML, Hunt SA, Carlson RW, Guardino AE. Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility. J Clin Oncol 2007;25:3525-33.
22. Heidenreich PA, Hancock SL, Vagelos RH, Lee BK, Schnittger I. Diastolic dysfunction after mediastinal irradiation. Am Heart J 2005;150:977-82.
23. McCullough PA, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002;106:416-22.
24. Anaissie EJ, Kontoyiannis DP, O'Brien S, Kantarjian H, Robertson L, Lerner S et al. Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Ann Intern Med 1998;129:559-66.
25. Frankel SR, Eardley A, Lauwers G, Weiss M, Warrell RP Jr. The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Intern Med 1992;117:292-6.
26. Miyakoshi S, Kami M, Yuji K, Matsumura T, Takatoku M, Sasaki M et al. Severe pulmonary complications in Japanese patients after bortezomib treatment for refractory multiple myeloma. Blood 2006;107:3492-4.
27. Schimpff S, Satterlee W, Young VM, Serpick A. Empiric Therapy with Carbenicillin and Gentamicin for Febrile Patients with Cancer and Granulocytopenia. N Engl J Med 1971;284:1061-5.
28. Gruson D, Hilbert G, Valentino R, Vargas F, Chene G, Bebear C et al. Utility of fiberoptic bronchoscopy in neutropenic patients admitted to the intensive care unit with pulmonary infiltrates. Crit Care Med 2000;28:2224-30.
29. Bergeron A, Porcher R, Sulahian A, de Bazelaire C, Chagnon K, Raffoux E et al. The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leucocyte count of patients with hematological malignancies. Blood 2012;119:1931-7.
30. Maury S, Mary JY, Rabian C, Schwarzinger M, Toubert A, Scieux C et al. Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients. Br J Hematol 2001;115:630-41.
31. Segal BH. Aspergillosis. N Engl J Med 2009;360:1870-84.
32. Nguyen MH, Leather H, Clancy CJ, Cline C, Jantz MA, Kulkarni V et al. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients. Biol Blood Marrow Transplant 2011;17:1043-50.
33. Drew WL. Laboratory diagnosis of cytomegalovirus infection and disease in immunocompromised patients. Current opinion in infectious diseases 2007;20:408-11.
34. Martino R, Bretagne S, Einsele H, Maertens J, Ullmann AJ, Parody R et al. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin Infect Dis 2005;40:67-78.
35. Tandon S, Batchelor A, Bullock R, Gascoigne A, Griffin M, Hayes N et al. Peri-operative risk factors for acute lung injury after elective oesophagectomy. Br J Anesth 2001; 86: 633-8.
36. Elias D, Honoré C, Ciuchendéa R, Billard V, Raynard B, Lo Dico R et al. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg. 2008;95:1164-71.
37. Azoulay E, Thiery G, Chevret S, Moreau D, Darmon M, Bergeron A et al. The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore) 2004;83:360-70.
38. Rabbat A, Chaoui D, Lefebvre A, Roche N, Legrand O, Lorut C et al. Is BAL useful in patients with acute myeloid leukemia admitted in ICU for severe respiratory complications? Leukemia 2008;22:1361-7.
39. Rano A, Agusti C, Jimenez P, Angrill J, Benito N, Danes C et al. Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures. Thorax 2001;56:379-87.
40. Murray PV, O'Brien ME, Padhani AR, Powles R, Cunningham D, Jeanes A et al. Use of first line bronchoalveolar lavage in the immunosuppressed oncology patient. Bone Marrow Transplant 2001;27:967-71.
41. Ewig S, Torres A, Riquelme R, El-Ebiary M, Rovira M, Carreras E et al. Pulmonary complications in patients with hematological malignancies treated at a respiratory ICU. Eur Respir J 1998;12:116-22.
42. Dunagan DP, Baker AM, Hurd DD, Haponik EF. Bronchoscopic evaluation of pulmonary infiltrates following bone marrow transplantation. Chest 1997;111:135-41.
43. Maitre B, Jaber S, Maggiore SM, Bergot E, Richard JC, Bakthiari H et al. Continuous positive airway pressure during fiberoptic bronchoscopy in hypoxemic patients. Am J Crit Care Med 2000;162:1063-7.
44. Antonelli M, Pennisi MA, Conti G, Bello G, Maggiore S, Michetti V et al. Fiberoptic bronchoscopy during noninva-sive positive pressure ventilation delivered by helmet. Intensive Care Med 2003;29:126-9.
45. Clouzeau B, Bui HN, Guilhon E, Grenouillet-Delacre M, Leger MS, Saghi T et al. Fiberoptic bronchoscopy under noninvasive ventilation and propofol target-controlled infusion in hypoxemic patients. Intensive Care Med 2011;37: 1969-75.
46. Chalumeau-Lemoine L, Stoclin A, Billard V, Laplanche A, Raynard B, Blot F. Flexible fiberoptic bronchoscopy and remifentanil target-controlled infusion in ICU: a preliminary study. Intensive Care Med 2012 [epub ahead of print].
47. Gonzalez-Angulo AM, Hennessy BT, Mills GB. Future of personalized medicine in oncology: a systems biology approach. J Clin Oncol 2010;28:2777-83.
48. Caux C, Zitvogel L. Recent successes of cancer immunotherapy: a new dimension in personalized medicine? Target Oncol 2012 Feb 15.
49. Mok TS, Wu YL, Thongprasert S, Yang CH, Chu DT, Saijo N et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009;361:947-57.
50. Briel M, Meade M, Mercat A, Brower RG, Talmor D, Walter SD et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 2010;303:865-73.